옵션 체인은 다양한 행사가격과 만기일에 대한 RLI의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 RLI에 대한 시장 심리를 평가합니다..

RLI (NYSE:RLI) 주식, 옵션 체인

RLI CORP

RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety and it derives a majority of its revenue from the Casualty segment.

General Motors Photo by Jonathan Weiss on Shutterstock

Earnings

Equities

News

Pre-Market Outlook

Markets

Trading Ideas

ZION

미국 주식 선물 지수가 하락하는 가운데, 화요일 투자자들의 주목을 받을 수 있는 주식은 다음과 같다: 1. 월스트리트는 제너럴 모터스(NYSE:GM)가 개장 전 1주당 2.43달러의 분기 이익과 445억 9천만 달러의 매출을 발표할 것으로 예상하고 있다. GM 주식은 시장 마감 후 0.8% 상승하여 49.31달러로 거래되었다.

화요일 주목해야 할 주식: 제너럴 모터스, 버라이즌, 록히드 마틴 그리고 2종목

RLI Corp

<p>Compass Point  analyst Casey Alexander   downgrades RLI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) from Buy to Neutral and lowers the price target from $82 to $76.</p>


Downgrades

Price Target

Analyst Ratings

Compass Point Downgrades RLI to Neutral, Lowers Price Target to $76

<p>JMP Securities  analyst Karol Chmiel   reiterates RLI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) from Market Perform to Market Perform.</p>


Reiteration

JMP Securities Reiterates Market Perform on RLIto Market Perform

<p>RLI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.84 by 9.52 percent. This is a 3.16 percent decrease over earnings of $0.95 per share from the same period last year.  The company reported quarterly sales of $397.09 million which missed the analyst consensus estimate of $400.51 million by 0.85 percent.  This is a 5.15 percent increase over sales of $377.63 million the same period last year.</p>


Earnings Beats

Earnings Misses

RLI Q1 Adj. EPS $0.92 Beats $0.84 Estimate, Sales $397.09M Miss $400.51M Estimate

AMTB

ASGN

BANC

BPOP

BRKL

BWFG

CACI

CBAN

CHDN

CHKP

COOP

CSLR

CVLG

New Oriental Education & Technology Group

EGBN

EPRT

GATX

GLPG

GSHD

HBNC

HCSG

IMAX

INBK

KALU

KREF

LRCX

MTDR

ODFL

ORLY

OSBC

OTIS

PLXS

PTEN

SEIC

Earnings Scheduled For April 23, 2025

<p>RLI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-04-23. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that RLI will report an <strong>earnings per share</strong> (EPS) of $0.86.</p>
<p>RLI bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Earnings History Snapshot</h3>
<p>In the previous earnings release, the company missed EPS by $0.11, leading to a 8.1% drop in the share price the following trading session.</p>
<p>Here's a look at RLI's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.52</td>
<td>0.49</td>
<td>0.67</td>
<td>0.80</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.41</td>
<td>0.66</td>
<td>0.86</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-8.0%</td>
<td>-2.0%</td>
<td>3.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745348539_0.png" alt="eps graph" /></p>
<h3>RLI Share Price Analysis</h3>
<p>Shares of RLI were trading at $75.42 as of April 21. Over the last 52-week period, shares are up 6.07%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/RLI/earnings"><strong>To track all earnings releases for RLI visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Outlook For RLI

WIIM

Brighthouse Financial, Inc. - Common Stock

BWIN

CINF

ERIE

HUIZ

ITIC

KMPR

KNSL

LMND

OSCR

PLMR

ROOT

RYAN

SKWD

TRUP

TWFG

ZBAO

Shares of insurance companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

<p>Keefe, Bruyette &amp; Woods  analyst Meyer Shields   maintains RLI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) with a Outperform and lowers the price target from $95 to $85.</p>


Keefe, Bruyette & Woods Maintains Outperform on RLI, Lowers Price Target to $85

RLI Transportation Partners With TruckerCloud To Provide RLI Transportation With Unified Telematic Insights Solutions

<p>Compass Point  analyst Casey Alexander   maintains RLI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) with a Buy and lowers the price target from $185 to $82.</p>


Compass Point Maintains Buy on RLI, Lowers Price Target to $82

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul>
<li>Seaport Global analyst Tom Curran downgraded the rating for <strong>Plug Power Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) from Neutral to Sell and announced a $1 price target. Plug Power shares closed at $2.08 on Friday. <a href="https://www.benzinga.com/quote/PLUG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Ryan Macwilliams downgraded <strong>RingCentral, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNG#NYSE">RNG</a>) from Overweight to Equal-Weight and lowered the price target from $45 to $37. RingCentral shares closed at $34.65 on Friday. <a href="https://www.benzinga.com/quote/RNG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Terence Flynn downgraded the rating for <strong>Intellia Therapeutics, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) from Overweight to Equal-Weight and lowered the price target from $56 to $11. Intellia Therapeutics shares closed at $10.99 on Friday. <a href="https://www.benzinga.com/quote/NTLA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Andrew Andersen downgraded <strong>RLI Corp</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) from Buy to Underperform and lowered the price target from $95 to $61. RLI shares closed at $72.48 on Friday. <a href="https://www.benzinga.com/quote/RLI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Nicholas Campanella downgraded <strong>Public Service Enterprise Group Incorporated</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEG#NYSE">PEG</a>) from Overweight to Equal-Weight. Public Service Enterprise shares closed at $88.05 on Friday. <a href="https://www.benzinga.com/quote/PEG/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
<p><strong>Considering buying RNG stock? Here&#8217;s what analysts think: </strong></p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="573" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27080704/image-205-1024x573.png" alt="" class="wp-image-751144" style="width:427px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27080704/image-205-1024x573.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27080704/image-205-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27080704/image-205-768x430.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27080704/image-205.png 1110w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>


NTLA

PLUG

This RingCentral Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul>
<li>Morgan Stanley slashed the price target for <strong>Intellia Therapeutics, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) from $56 to $11. Morgan Stanley analyst Terence Flynn downgraded the stock from Overweight to Equal-Weight. Intellia Therapeutics shares closed at $10.99 on Friday. <a href="https://www.benzinga.com/quote/NTLA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays cut <strong>McCormick &amp; Company, Incorporated</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) price target from $85 to $82. Barclays analyst Andrew Lazar maintained an Equal-Weight rating. McCormick shares closed at $74.89 on Friday. <a href="https://www.benzinga.com/quote/MKC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays raised the price target for <strong>Abbott Laboratories</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) from $149 to $158. Barclays analyst Matt Miksic maintained an Overweight rating. Abbott shares closed at $125.03 on Friday. <a href="https://www.benzinga.com/quote/ABT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Goldman Sachs raised the price target for <strong>Twilio Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) from $77 to $185. Goldman Sachs analyst Kash Rangan upgraded the stock from Neutral to Buy. Twilio shares closed at $136.23 on Friday. <a href="https://www.benzinga.com/quote/TWLO/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies cut <strong>RLI Corp</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) price target from $95 to $61. Jefferies analyst Andrew Andersen downgraded the stock from Buy to Underperform. RLI shares settled at $72.48 on Friday. <a href="https://www.benzinga.com/quote/RLI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley raised <strong>Exelixis, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) price target from $30 to $40. Morgan Stanley analyst Jefferson Harralson upgraded the stock from Equal-Weight to Overweight. Exelixis shares closed at $32.38 on Friday. <a href="https://www.benzinga.com/quote/EXEL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan decreased <strong>Omnicom Group Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMC#NYSE">OMC</a>) price target from $119 to $116. JP Morgan analyst David Karnovsky maintained an Overweight rating. Omnicom shares closed at $86.56 on Friday.  <a href="https://www.benzinga.com/quote/OMC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel raised the price target for <strong>Portillo&#8217;s Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTLO#NASDAQ">PTLO</a>) from $13 to $16. Stifel analyst Chris O&#8217;Cull upgraded the stock from Hold to Buy. Portillo&#8217;s shares settled at $12.49 on Friday. <a href="https://www.benzinga.com/quote/PTLO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays cut <strong>RingCentral, Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNG#NYSE">RNG</a>) price target from $45 to $37. Barclays analyst Ryan Macwilliams downgraded the stock from Overweight to Equal-Weight. RingCentral shares closed at $34.65 on Friday. <a href="https://www.benzinga.com/quote/RNG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler increased <strong>Qorvo, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) price target from $85 to $110. Piper Sandler analyst Harsh Kumar upgraded the stock from Neutral to Overweight. Qorvo shares closed at $88.94 on Friday. <a href="https://www.benzinga.com/quote/QRVO/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
<p><strong>Read This Next:</strong></p>
<ul>
<li><strong> <a href="https://www.benzinga.com/markets/25/01/43189390/top-3-materials-stocks-that-may-fall-off-a-cliff-in-january">Top 3 Materials Stocks That May Fall Off A Cliff In January</a></strong></li>
</ul>


EXEL

PTLO

QRVO

TWLO

Abbott To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday

<p>Jefferies  analyst Andrew Andersen   downgrades RLI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) from Buy to Underperform and lowers the price target from $95 to $61.</p>


Jefferies Downgrades RLI to Underperform, Lowers Price Target to $61

<p>RBC Capital  analyst Scott Heleniak   maintains RLI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) with a Sector Perform and lowers the price target from $88 to $80.</p>


RBC Capital Maintains Sector Perform on RLI, Lowers Price Target to $80

<p>The earnings results for <strong>RLI</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) for Q4 were made public on Wednesday, January 22, 2025 at 04:05 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>RLI missed estimated earnings by -21.0%, reporting an EPS of $0.41 versus an estimate of $0.52.</p>
<p>Revenue was up $35.56 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>The company beat on EPS by $0.34 in the previous quarter, leading to a 2.0% drop share price change the next day.</p>
<p>Here's a look at RLI's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.97</td>
<td>1.34</td>
<td>1.60</td>
<td>1.49</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.31</td>
<td>1.72</td>
<td>1.89</td>
<td>1.54</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>389.49M</td>
<td>443.66M</td>
<td>367.78M</td>
<td>357.64M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>401.54M</td>
<td>459.90M</td>
<td>377.63M</td>
<td>330.90M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for RLI <a href="https://www.benzinga.com/quote/RLI/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


RLI Q4 Earnings Assessment

<p><strong>RLI</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) just disclosed its Q4 earnings on Wednesday, January 22, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>RLI missed estimated earnings by -21.0%, reporting an EPS of $0.41 versus an estimate of $0.52.</p>
<p>Revenue was up $35.56 million from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>Last quarter the company beat on EPS by $0.34 which was followed by a 2.0% drop in the share price the next day.</p>
<p>Here's a look at RLI's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.97</td>
<td>1.34</td>
<td>1.60</td>
<td>1.49</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.31</td>
<td>1.72</td>
<td>1.89</td>
<td>1.54</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>389.49M</td>
<td>443.66M</td>
<td>367.78M</td>
<td>357.64M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>401.54M</td>
<td>459.90M</td>
<td>377.63M</td>
<td>330.90M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for RLI <a href="https://www.benzinga.com/quote/RLI/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Summary: RLI Q4

<p><strong>RLI</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) released its Q4 earnings on Wednesday, January 22, 2025 at 04:05 PM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>RLI missed estimated earnings by -21.0%, reporting an EPS of $0.41 versus an estimate of $0.52.</p>
<p>Revenue was up $35.56 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>In the previous quarter, the company beat on EPS by $0.34, resulting in a 2.0% drop change in the share price the following day.</p>
<p>Here's a look at RLI's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.97</td>
<td>1.34</td>
<td>1.60</td>
<td>1.49</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.31</td>
<td>1.72</td>
<td>1.89</td>
<td>1.54</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>389.49M</td>
<td>443.66M</td>
<td>367.78M</td>
<td>357.64M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>401.54M</td>
<td>459.90M</td>
<td>377.63M</td>
<td>330.90M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for RLI <a href="https://www.benzinga.com/quote/RLI/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Insights into RLI Q4 Earnings

<p><strong>RLI</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) just disclosed its Q4 earnings on Wednesday, January 22, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>RLI missed estimated earnings by -21.0%, reporting an EPS of $0.41 versus an estimate of $0.52.</p>
<p>Revenue was up $35.56 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>During the previous quarter, the company beat on EPS by $0.34, leading to a 2.0% drop share price change the next day.</p>
<p>Here's a look at RLI's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.97</td>
<td>1.34</td>
<td>1.60</td>
<td>1.49</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.31</td>
<td>1.72</td>
<td>1.89</td>
<td>1.54</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>389.49M</td>
<td>443.66M</td>
<td>367.78M</td>
<td>357.64M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>401.54M</td>
<td>459.90M</td>
<td>377.63M</td>
<td>330.90M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for RLI <a href="https://www.benzinga.com/quote/RLI/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


RLI: Q4 Earnings Insights

RLI shares are trading lower following worse-than-expected Q4 financial results.

<p><strong>RLI</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) announced its Q4 earnings on Wednesday, January 22, 2025 at 04:05 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>RLI missed estimated earnings by -21.0%, reporting an EPS of $0.41 versus an estimate of $0.52.</p>
<p>Revenue was up $35.56 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>Last quarter the company beat on EPS by $0.34 which was followed by a 2.0% drop in the share price the next day.</p>
<p>Here's a look at RLI's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.97</td>
<td>1.34</td>
<td>1.60</td>
<td>1.49</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.31</td>
<td>1.72</td>
<td>1.89</td>
<td>1.54</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>389.49M</td>
<td>443.66M</td>
<td>367.78M</td>
<td>357.64M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>401.54M</td>
<td>459.90M</td>
<td>377.63M</td>
<td>330.90M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for RLI <a href="https://www.benzinga.com/quote/RLI/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


RLI Earnings Report: Q4 Overview

Press Releases

RLI Declares Special Dividend and Two-for-One Stock Split

RLI Fourth Quarter earnings release & teleconference

RLI Reports Fourth Quarter and Year-End 2024 Results

RLI Named as One of the Best Places to Work in 2025, a Glassdoor Employees' Choice Award Winner

AM Best Revises Outlooks to Positive for RLI Corp. and Its Subsidiaries

AM Best Affirms A+ (Superior) Rating and Revises Outlook to Positive for RLI Corp., RLI Insurance Co., Mt. Hawley Insurance Co. and Contractors Bonding and Insurance Co.

Comments

RLI

RLI (RLI) 옵션

RLI (NYSE:RLI) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌